Lindsay Kilburn, MD Neuro-Oncologist

Bio

Biography

Lindsay Kilburn, MD, comes to Children's National Health System from Texas Children’s Hospital in Houston, TX, where she was an assistant professor of pediatrics in the neuro-oncology and pharmacology programs. 

Dr. Kilburn graduated with a degree in Environmental Sciences from the University of Virginia. After graduating from Eastern Virginia Medical School, she completed her pediatric training at the Children’s Hospital of The King’s Daughters in Norfolk, VA, and her hematology/oncology fellowship at Texas Children’s Hospital/Baylor College of Medicine in Houston, TX. She also has received training in pharmacology from both Thomas Jefferson University in Philadelphia and the Baylor College of Medicine in Houston. Her research focuses on the development and evaluation of new therapeutic agents for children with pediatric brain tumors through clinical trials. She is committed to the improvement of palliative and supportive care. Dr. Kilburn grew up outside of Philadelphia and is married with young twins. Outside of work, she enjoys sailing, hiking, and traveling with her family.

Education & Training

Education & Training

  • MD, 2001
    Eastern Virginia Medical School
  • BA, 1995
    University of Virginia
Patient Stories

Patient Stories: Lindsay Kilburn, MD

Jackson's Story

"I have become a total advocate for my child, fighting this fight right alongside of him."

Patient story

Mason's Story

"You are about to embark on a journey that will be the challenge of your life as a parent. But you have chosen a hospital and a brain tumor treatment team that is one of the best in the country."

Keith's Story

"You will find new strength you didn't know you had. You will find that what seemed to be the daily grind of work or home life will take on new meaning and will sustain you by the sheer normalness of it."

Research & Publications

Research & Publications

Intrathecal Chemotherapy

(0001) Handbook of Anticancer Agents Pharmacokinetics and Pharmacodynamics

Clinical Assessment of Differential Diagnosis of the Child with Suspected Cancer

(0001) For Principles and Practice of Pediatric Oncology

Glutathione STransferase M1 and T1 Polymorphisms May Predict Adverse Effects After Therapy in Children with Medulloblastoma

(2009) Neuro Oncol

Plasma and Cerebrospinal Fluid Pharmacokinetics of Tasidotin ILX651 and its Metobolites in NonHuman Primates

(2009) Cancer Chemother Pharmacol

See More on PubMed

Invest in future cures for some of life's most devastating diseases

See other ways to give

Run or walk with us on September 13th and help local kids!

Race for Every Child Logo Register now

Staci's Story

Patient story

"As a parent/caretaker, you want to fight with every ounce of fight that you have. It's normal and necessary to help you feel like you are fighting right along with your precious baby."

Read More of Staci's Story